Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Ligand Pharmaceuticals Incorporated”

124 pharma patents match "Ligand Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 124
Index total 30,257
Page 1 / 6

Quick answer

This filtered view shows 124 pharmaceutical patents matching "Ligand Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

124 results for “Ligand Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 12403087

    Topical antiviral compositions, delivery systems, and methods of using the same

    Ligand Pharmaceuticals Incorporated · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted

  2. US 12319651

    Crystalline forms and methods of producing crystalline forms of a compound

    Ligand Pharmaceuticals Incorporated · Granted Jun 3, 2025 · Expires May 29, 2045

    granted

  3. US 12208071

    Glucagon receptor antagonists

    Ligand Pharmaceuticals Incorporated · Granted Jan 28, 2025 · Expires Jan 23, 2045

    granted

  4. US 11970482

    Acetal compounds and therapeutic uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted

  5. US 11773110

    Heterocycle amines and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  6. US 11566041

    Nucleotide prodrug compounds

    Ligand Pharmaceuticals Incorporated · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

  7. US 11413274

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  8. US 11358931

    Selective androgen receptor modulators (SARMs) and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  9. US 11278559

    Prodrug compounds and their uses

    Ligand Pharmaceuticals Incorporated · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

  10. US 11186593

    Heterocycle amines and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  11. US 10874638

    Methods and compositions for modulating hormone levels

    Ligand Pharmaceuticals Incorporated · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  12. US 10736875

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  13. US 10730831

    Selective androgen receptor modulators (SARMs) and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  14. US 10604533

    Heterocycle amines and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

  15. US 10449210

    Prodrug compounds and their uses

    Ligand Pharmaceuticals Incorporated · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  16. US 10441567

    Methods and compositions for modulating hormone levels

    Ligand Pharmaceuticals Incorporated · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  17. US 10420748

    Methods of treatment associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

  18. US 10150788

    Prodrug compounds and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  19. US 10111859

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  20. US 10106500

    Selective androgen receptor modulators (SARMs) and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  21. US 10030034

    Heterocycle amines and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted

  22. US 10000522

    Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections

    Ligand Pharmaceuticals Incorporated · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted

  23. US 9993461

    Method for treating disorders associated with glomerular function

    Ligand Pharmaceuticals Incorporated · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted

  24. US 9994600

    Prodrug compounds and uses therof

    Ligand Pharmaceuticals Incorporated · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.